Skip to main content

News Archive

Events for the below selected month

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes

Posted 09 Jul 2019

From The Lancet

The results show compelling evidence of the substantial impact of HPV vaccination programmes on HPV infections and CIN2+ among girls and women, and on anogenital warts diagnoses among girls, women, boys, and men. Additionally, programmes with... Read more

Head & Neck Cancer Patient Treated with Innovative Radiotherapy Treatment

Posted 30 Jun 2019

UK first

A woman from Salisbury has become the first patient in the UK with head and neck cancer to receive radiotherapy in the operating theatre during surgery to remove a recurrent tumour. Jayne Garrett, 53, underwent major surgery at University... Read more

Head & Neck cancer patient receives radiotherapy during surgery

Posted 28 Jun 2019

BAHNO members involved in UK first

A woman has become the first patient in the UK with head & neck cancer to receive radiotherapy during surgery to remove a recurrent tumour. Jayne Garrett underwent major surgery at University Hospital, Southampton after suffering a recurrence of... Read more

ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer

Posted 05 Jun 2019

Media release: The Institute of Cancer Research, London

Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show. At diagnosis, people with head and... Read more

The Waterside Ape - an alternative account of human evolution

Posted 03 Jun 2019

New book available by Mr Peter Rhys Evans

  Have you ever wondered why humans have such an affinity for water and the sea, unlike any other primate? Why some people have dark skin and others have paler skin? Why we lost our fur and are the only Naked Ape? Why, out of over 4,000 land... Read more

Professor Maura L Gillison presents at BAHNO

Posted 20 May 2019

Packed auditorium hears American Professor’s lecture

Professor Maura L Gillison was the Blair Hesketh invited speaker at the recent BAHNO Annual Scientific Meeting.  Over 300 delegates listened to her presentation on the management of HPV and oropharyngeal cancer and a lively case-based panel... Read more

The President’s Awards

Posted 20 May 2019

Outstanding surgeons recognised

At his final AGM as President of BAHNO, Professor Hisham Mehanna took the opportunity to honour four surgeons who have contributed greatly to BAHNO and to the specialty. Mr Michael Fardy and Mr Nicholas Roland were given Honorary Life Membership... Read more

Doctors team up to treat 'untreatable growth' - and the results are 'miraculous'

Posted 10 May 2019

Patient told his condition was incurable until two Teesside surgeons stepped in to change his life

Fantastic news from Teesside!  Please read the article here. From Teesside Live NHS. Read more

FAQ Discussion Guide for Patients Diagnosed with Head & Neck Cancer launched

Posted 01 May 2019

Make Sense Campaign launches booklet for patients

A diagnosis of head and neck cancer can be shocking and in the following weeks will have you navigating through your medical system. During this time, conversations with your healthcare professionals will be intense and, sometimes, short, but you... Read more

BAHNO Annual Scientific Meeting

Posted 18 Apr 2019

Friday 17th May 2019

The BAHNO meeting this year has been accredited 6 CPD points by the Royal College of Surgeons of England. Register here Registrations on the day will incur a £50 administrative charge! Read more

Dynamic host immune response in virus-associated cancers

Posted 29 Mar 2019

Abstract Viruses drive carcinogenesis in human cancers through diverse mechanisms that have not been fully elucidated but include promoting immune escape. Here we investigated associations between virus-positivity and immune pathway alteration... Read more

Non-murine models to investigate tumor-immune interactions in head and neck cancer

Posted 29 Mar 2019

On-line article

The immune response has important roles in the biology of solid tumors, including oncogenesis, tumor growth, invasion and metastasis, and response to treatment. Improved understanding of tumor-immune system interactions has provided promising... Read more

Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach

Posted 29 Mar 2019

From the British Journal of Cancer

Background TNM8 staging for oropharyngeal squamous cell carcinomas (OPSCC) surrogates p16 immunohistochemistry for HPV testing. Patients with p16+ OPSCC may lack HPV aetiology. Here, we evaluate the suitability of TNM8 staging for guiding... Read more

Summary of the European public assessment report (EPAR) for Erbitux

Posted 29 Mar 2019

European Medicines Agency

This is a summary of the European public assessment report (EPAR) for Erbitux. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and... Read more

Review of inbound medical tourism and legal details of obtaining a visa for treatment of head and neck cance

Posted 29 Mar 2019

Case report from the United States

Methods We reviewed current statistics and the medical and legal literature regarding inbound medical tourism and the process of obtaining a visa for patients traveling to the United States for medical treatment. To illustrate this process, we... Read more

Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma

Posted 15 Mar 2019

Scientific Report

Recently, exosomes secreted by menstrual mesenchymal stem cells have been identified as inhibitory agents of tumor angiogenesis and modulators of the tumor cell secretome in prostate and breast cancer. However, their direct effect on endothelial... Read more

Bill introduced to make oral cancer medication more affordable

Posted 15 Mar 2019

News from America

WASHINGTON, D.C. — There’s a new effort on Capitol Hill to make newer cancer treatment options more affordable. U.S. Senator Tina Smith (D-Minnesota) along with U.S. Senator Jerry Moran (R-Kansas) re-introduced the “Cancer Drug Parity Act”... Read more

The NKG2A immune checkpoint

Posted 15 Mar 2019

A new direction in cancer immunotherapy

Inhibition of the NKG2A immune checkpoint restores natural killer cell and T cell effector function in preclinical cancer models. In addition, NKG2A blockade in combination with other therapeutic antibodies is showing encouraging responses in a... Read more

Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy

Posted 15 Mar 2019

Hopes for earlier diagnosis and better survival outcome in patients with head and neck cancer.

Patients with head and neck squamous cell carcinoma are at increased risk of developing a second primary malignancy, which is associated with poor prognosis and early death. To help improve clinical outcome, we aimed to identify biomarkers for... Read more

Depiction of Oral Tumor-Induced Trigeminal Afferent Responses Using Single-Fiber Electrophysiology

Posted 15 Mar 2019

Considerable gap in knowledge exists about the mechanisms by which oral tumors regulate peripheral sensory fibers to produce pain and altered sensations. To address this gap, we used a murine model of oral squamous cell carcinoma (OSCC) of the... Read more